National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Vitae Pharmaceuticals

Therapeutic Approach

Oral Treatments

Indication

Psoriasis

Mechanism

anti-inflammatory (IL-17 blocker)

Phase

Phase II

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.